Roy A Whitfield insider trades

Open-market stock purchases and sales by Roy A Whitfield, Unknown at Nektar Therapeutics, from SEC Form 4 filings since Jan 25, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +54%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • NKTR Nektar Therapeutics: 4 buys, 2 sales, last Sep 30, 2025
  • ILMN Illumina Inc: 28 sales, last Aug 12, 2016
  • INCY Incyte Corp: 91 sales, last Dec 17, 2013

Get free alerts when Roy A Whitfield files a new trade →